These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35350239)

  • 1. Mechanism Analysis of LINC00665 and Its Peptides CIP2A-BP in Hepatocellular Carcinoma.
    Li YR; Zong RQ; Zhang HY; Meng XY; Wu FX
    Front Genet; 2022; 13():861096. PubMed ID: 35350239
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
    Wen DY; Lin P; Pang YY; Chen G; He Y; Dang YW; Yang H
    Med Sci Monit; 2018 May; 24():2786-2808. PubMed ID: 29728556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Intergenic Non-Protein Coding RNA 665 Regulates Viability, Apoptosis, and Autophagy via the MiR-186-5p/MAP4K3 Axis in Hepatocellular Carcinoma.
    Shan Y; Li P
    Yonsei Med J; 2019 Sep; 60(9):842-853. PubMed ID: 31433582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA LINC00665 is a diagnostic biomarker that enhances cell proliferation and migration in hepatocellular carcinoma.
    Li Z; Yuan J; Yan Z; Liu X; Liu J
    Int J Clin Exp Pathol; 2023; 16(11):332-343. PubMed ID: 38059173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics.
    Zhong C; Xie Z; Shen J; Jia Y; Duan S
    Cells; 2022 May; 11(9):. PubMed ID: 35563845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CIP2A is highly expressed in hepatocellular carcinoma and predicts poor prognosis.
    He H; Wu G; Li W; Cao Y; Liu Y
    Diagn Mol Pathol; 2012 Sep; 21(3):143-9. PubMed ID: 22847158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC00665 Targets miR-214-3p/MAPK1 Axis to Accelerate Hepatocellular Carcinoma Growth and Warburg Effect.
    Wan H; Tian Y; Zhao J; Su X
    J Oncol; 2021; 2021():9046798. PubMed ID: 34804162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma.
    Li W; Chen QF; Huang T; Wu P; Shen L; Huang ZL
    Front Oncol; 2020; 10():780. PubMed ID: 32587825
    [No Abstract]   [Full Text] [Related]  

  • 11. Downregulation of LINC00665 confers decreased cell proliferation and invasion via the miR-138-5p/E2F3 signaling pathway in NSCLC.
    Wang H; Wang L; Zhang S; Xu Z; Zhang G
    Biomed Pharmacother; 2020 Jul; 127():110214. PubMed ID: 32403047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC00665 facilitates the progression of osteosarcoma via sponging miR-3619-5p.
    Zhang DW; Gu GQ; Chen XY; Zha GC; Yuan Z; Wu Y
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9852-9859. PubMed ID: 33090388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of CIP2A attenuates tumor progression by inducing cell cycle arrest and promoting cellular senescence in hepatocellular carcinoma.
    Yang X; Qu K; Tao J; Yin G; Han S; Liu Q; Sun H
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1807-1814. PubMed ID: 29175329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
    Yan Z; He M; He L; Wei L; Zhang Y
    Front Immunol; 2021; 12():723271. PubMed ID: 34925311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC00665 promotes the viability, migration and invasion of T cell acute lymphoblastic leukemia cells by targeting miR-101 via modulating PI3K/Akt pathway.
    Abuduer M; A EZG
    Tissue Cell; 2021 Aug; 71():101579. PubMed ID: 34171521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA LINC00665 promotes metastasis of breast cancer cells by triggering EMT.
    Zhou JL; Zou L; Zhu T
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3097-3104. PubMed ID: 32271427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
    Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z
    BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non‑coding RNA‑based risk scoring system predicts prognosis of alcohol‑related hepatocellular carcinoma.
    Luo Y; Ye J; Wei J; Zhang J; Li Y
    Mol Med Rep; 2020 Aug; 22(2):997-1007. PubMed ID: 32468063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.